CD8A and breast carcinoma: Specifically, antigen-LAMP1 fusion construct displayed a significantly higher percentage of CD8 T cells secreting interferon (IFN)γ and tumor necrosis factor (TNF)α leading to better survival compared to construct with antigen alone in a breast cancer mouse model, indicating the advantage of using UNITE platform (14).